Pure Global
NCT06409611

MUSCLE EFFECTS OF NEUROMUSCULAR ELECTROSTIMULATION IN MECHANICALLY VENTILATED PATIENTS IN AN ICU

Universidade Federal do Rio de Janeiro·ClinicalTrials.gov·device·Device trialNot yet recruiting
View on ClinicalTrials.gov →
Study focus
Disease/Condition
Intensive Care Unit Acquired Weakness
Drug/Device/Intervention
neuromuscular electrical stimulation
Study type
Interventional
Intervention type
device
Sponsor & location
Primary sponsor
Universidade Federal do Rio de Janeiro
Location
Rio De Janeiro, Brazil
Timeline & enrollment
Phase
N/A
Start date
May 01, 2024
End date
Apr 01, 2026
Enrollment
22 participants
Primary outcome

Pennation angle (degrees)

Summary

To prevent the development of ICUAW, both early mobilization and neuromuscular electrical
 stimulation (NMES) have been shown to prevent muscle atrophy in critically ill patients by
 preserving muscle mass. Furthermore, it is of great value that muscle assessment using
 kinesiological ultrasound becomes routine to monitor this patient's profile with regard to
 strength, muscle quality and muscle mass. Our objective is to evaluate the muscular changes
 promoted by NMES in patients under mechanical ventilation. This is a randomized clinical
 trial study, which will perform NMES sessions for at least 10 days in mechanically ventilated
 patients. They will also undergo ultrasound assessments of the quadriceps. Patients will be
 divided into a control group and an NMES group. In addition, general information recorded in
 the medical record will be collected, such as basic characteristics, laboratory tests and
 general assessments.

ICD-10 classifications
Acute respiratory failureAcute renal failure with medullary necrosisAcute renal failureAcute renal failure, unspecifiedOther acute renal failure
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06409611
Type
Device Trial
About this record

Access comprehensive clinical trial information for NCT06409611 through Pure Global AI's free database. This phase not specified trial is sponsored by Universidade Federal do Rio de Janeiro and is currently Not yet recruiting. The study focuses on Intensive Care Unit Acquired Weakness. Target enrollment is 22 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.